Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Topiramate 25mg tablets
040801050AAADAD
|
Topiramate | Topiramate | Central Nervous System | 72,198 |
|
Topiramate 50mg tablets
040801050AAAAAA
|
Topiramate | Topiramate | Central Nervous System | 70,739 |
|
Topiramate 100mg tablets
040801050AAABAB
|
Topiramate | Topiramate | Central Nervous System | 51,281 |
|
Topiramate 200mg tablets
040801050AAACAC
|
Topiramate | Topiramate | Central Nervous System | 10,393 |
|
Topiramate 25mg capsules
040801050AAAVAV
|
Topiramate | Topiramate | Central Nervous System | 9,259 |
|
Topiramate 50mg capsules
040801050AAAWAW
|
Topiramate | Topiramate | Central Nervous System | 6,783 |
|
Topiramate 15mg capsules
040801050AAAUAU
|
Topiramate | Topiramate | Central Nervous System | 2,852 |
|
Topiramate 50mg/5ml oral suspension sugar free
040801050AACGCG
|
Topiramate | Topiramate | Central Nervous System | 1,794 |
|
Topiramate 100mg/5ml oral suspension sugar free
040801050AACHCH
|
Topiramate | Topiramate | Central Nervous System | 912 |
|
Topiramate 25mg/5ml oral suspension
040801050AABXBX
|
Topiramate | Topiramate | Central Nervous System | 303 |
|
Topiramate 50mg/5ml oral suspension
040801050AAARAR
|
Topiramate | Topiramate | Central Nervous System | 14 |
|
Topiramate 100mg/5ml oral suspension
040801050AAAZAZ
|
Topiramate | Topiramate | Central Nervous System | 10 |
|
Topiramate 100mg/5ml oral solution
040801050AACCCC
|
Topiramate | Topiramate | Central Nervous System | 7 |
|
Topiramate 20mg/ml oral solution sugar free
040801050AACICI
|
Topiramate | Topiramate | Central Nervous System | 3 |
|
Topiramate 10mg/5ml oral liquid
040801050AAAQAQ
|
Topiramate | Topiramate | Central Nervous System | No data available |
|
Topiramate 12.5mg/5ml oral liquid
040801050AAAXAX
|
Topiramate | Topiramate | Central Nervous System | No data available |
|
Topiramate 125mg/5ml oral liquid
040801050AAAYAY
|
Topiramate | Topiramate | Central Nervous System | No data available |
|
Topiramate 12mg/5ml oral liquid
040801050AABPBP
|
Topiramate | Topiramate | Central Nervous System | No data available |
|
Topiramate 150mg/5ml oral liquid
040801050AABSBS
|
Topiramate | Topiramate | Central Nervous System | No data available |
|
Topiramate 15mg/5ml oral liquid
040801050AABVBV
|
Topiramate | Topiramate | Central Nervous System | No data available |
|
Topiramate 16mg/5ml oral liquid
040801050AABTBT
|
Topiramate | Topiramate | Central Nervous System | No data available |
|
Topiramate 200mg/5ml oral liquid
040801050AABABA
|
Topiramate | Topiramate | Central Nervous System | No data available |
|
Topiramate 20mg/5ml oral liquid
040801050AABDBD
|
Topiramate | Topiramate | Central Nervous System | No data available |
|
Topiramate 250mg/5ml oral suspension
040801050AABZBZ
|
Topiramate | Topiramate | Central Nervous System | No data available |
|
Topiramate 25mg/5ml oral solution
040801050AACECE
|
Topiramate | Topiramate | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.